XGN
Ticker
Exagen Inc.
XGN · Healthcare · Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United StatesExagen Inc. (XGN), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 1 purchase and 2 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Oct 19 and filed Oct 20. The most active filer was John Aballi with 1 filing. Data as of Nov 7 2026.
Add to watchlistFilings, ttm
3
1 buy · 2 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$523K
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Oct 19
Filed Oct 20
ADViAverage daily dollar volume
$2.3M
market data
Share price · 12M
$7.27 (-23.2%)
Adjusted for splits and dividends.
Volume by month
Buys $104K
Sells $2.1M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
JARecent filings
Jorey ChernettPURCHASE
10% owner
$104K14,000 sh × $7.46
Exec Oct 19
Filed Oct 20 · 8:00 AM ET John AballiSALE President and CEO $270K
34,294 sh × $7.87
Exec Oct 16
Filed Oct 19 · 4:52 PM ET Jeffrey G. BlackSALE Chief Financial Officer $149K
20,614 sh × $7.22
Exec Sep 1
Filed Sep 2 · 5:39 PM ET John AballiSALE President and CEO $376K
31,787 sh × $11.82
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET Jeffrey G. BlackSALE Chief Financial Officer $200K
20,466 sh × $9.79
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET NMSIC Co-Investment Fund, L.P.SALE 10% owner $1.2M
350,000 sh × $3.30
Exec Mar 25 2025
Filed Mar 27 2025 · 5:30 PM ET Sun Mountain Capital Partners LLCSALE 10% owner $660K
200,000 sh × $3.30
Exec Nov 20 2024
Filed Nov 27 2024 · 5:30 PM ET †